Enfusion (NYSE:ENFN) Sees Strong Trading Volume – Here’s Why

Enfusion, Inc. (NYSE:ENFN) saw unusually-high trading volume on Friday . Approximately 1,006,729 shares changed hands during mid-day trading, an increase of 168% from the previous session’s volume of 375,878 shares.The stock last traded at $9.45 and had previously closed at $9.30.

Enfusion Price Performance

The company has a market capitalization of $1.20 billion, a price-to-earnings ratio of 232.50, a PEG ratio of 2.42 and a beta of 0.93. The stock has a 50 day simple moving average of $8.82 and a two-hundred day simple moving average of $8.85.

Enfusion (NYSE:ENFN) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). Enfusion had a return on equity of 6.93% and a net margin of 1.70%. The business had revenue of $49.46 million for the quarter, compared to analyst estimates of $50.27 million. Equities research analysts predict that Enfusion, Inc. will post 0.07 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Dimensional Fund Advisors LP increased its stake in Enfusion by 57.5% during the second quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company’s stock worth $4,466,000 after acquiring an additional 191,436 shares during the last quarter. Impax Asset Management Group plc raised its stake in Enfusion by 25.4% during the third quarter. Impax Asset Management Group plc now owns 676,948 shares of the company’s stock valued at $6,424,000 after buying an additional 136,948 shares in the last quarter. Scalar Gauge Management LLC increased its stake in Enfusion by 21.8% during the second quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company’s stock valued at $5,227,000 after purchasing an additional 110,000 shares during the last quarter. SG Americas Securities LLC acquired a new position in Enfusion in the third quarter valued at approximately $892,000. Finally, Squarepoint Ops LLC bought a new position in shares of Enfusion during the second quarter worth about $683,000. Institutional investors and hedge funds own 81.05% of the company’s stock.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.